Insider Profile
Medline, Michael Bennett
2
Companies Filed At
2
Open-Market Buys (2yr)
$800K
Buy Value (2yr, open-market)
Apr 28, 2026
Most Recent Trade
Cross-Company Track Record
across 2 issuers · entity-resolved
33%
Hit Rate · 90d
-3.5%
Median Alpha · 90d
3
Closed Buys Evaluated
33%
Beat XIU
2
Issuers Traded
All-insider base rate:
59% hit rate
· +1.3% mean alpha
(n=11504)
multi issuer
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later.
Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research
3 closed buys with individual return outcomes available on the
Research plan.
| Date | Company | Dir. | Value |
|---|---|---|---|
| Apr 28, 2026 |
$BNS
Bank of Nova Scotia
|
Buy | $86K |
| Apr 28, 2026 |
$BNS
Bank of Nova Scotia
|
Buy | $11K |
| Mar 12, 2026 |
$TRI
Thomson Reuters Corp
|
Buy | $500K |
| Jan 28, 2026 |
$BNS
Bank of Nova Scotia
|
Buy | $10K |
| Jan 28, 2026 |
$BNS
Bank of Nova Scotia
|
Buy | $86K |
| Jan 05, 2026 |
$TRI
Thomson Reuters Corp
|
Sell | — |
| Oct 29, 2025 |
$BNS
Bank of Nova Scotia
|
Buy | $81K |
| Oct 29, 2025 |
$BNS
Bank of Nova Scotia
|
Buy | $9K |
| Jul 29, 2025 |
$BNS
Bank of Nova Scotia
|
Buy | $81K |
| Jul 29, 2025 |
$BNS
Bank of Nova Scotia
|
Buy | $8K |
| Apr 28, 2025 |
$BNS
Bank of Nova Scotia
|
Buy | $72K |
| Apr 28, 2025 |
$BNS
Bank of Nova Scotia
|
Buy | $7K |
| Jan 29, 2025 |
$BNS
Bank of Nova Scotia
|
Buy | $69K |
| Jan 29, 2025 |
$BNS
Bank of Nova Scotia
|
Buy | $5K |
| Oct 29, 2024 |
$BNS
Bank of Nova Scotia
|
Buy | $4K |
| Oct 29, 2024 |
$BNS
Bank of Nova Scotia
|
Buy | $69K |
| Aug 29, 2024 |
$BNS
Bank of Nova Scotia
|
Buy | $300K |
| Apr 26, 2024 |
$BNS
Bank of Nova Scotia
|
Buy | $2K |
| Apr 26, 2024 |
$BNS
Bank of Nova Scotia
|
Buy | $69K |
| Feb 29, 2024 |
$BNS
Bank of Nova Scotia
|
Buy | $196K |
| Jan 29, 2024 |
$BNS
Bank of Nova Scotia
|
Buy | $878 |
| Jan 29, 2024 |
$BNS
Bank of Nova Scotia
|
Buy | $69K |
| Oct 27, 2023 |
$BNS
Bank of Nova Scotia
|
Buy | $46K |
Muted rows are plan purchases, compensation grants, or DRIP — not open-market.
Confluence Scores reflect the company's current score, not the score at time of trade.